155 related articles for article (PubMed ID: 15452163)
1. c-KIT and PDGFRA in breast phyllodes tumours: overexpression without mutations?
Carvalho S; e Silva AO; Milanezi F; Ricardo S; Leitão D; Amendoeira I; Schmitt FC
J Clin Pathol; 2004 Oct; 57(10):1075-9. PubMed ID: 15452163
[TBL] [Abstract][Full Text] [Related]
2. Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit.
Sawyer EJ; Poulsom R; Hunt FT; Jeffery R; Elia G; Ellis IO; Ellis P; Tomlinson IP; Hanby AM
J Pathol; 2003 May; 200(1):59-64. PubMed ID: 12692842
[TBL] [Abstract][Full Text] [Related]
3. Mutational spectrum and classification of novel mutations in patients with metastatic gastrointestinal stromal tumours.
Bombac A; Zakotnik B; Bucic M; Setrajcic Dragos V; Gazic B; Stegel V; Klancar G; Novakovic S
Int J Oncol; 2020 Jun; 56(6):1468-1478. PubMed ID: 32236636
[TBL] [Abstract][Full Text] [Related]
4. Mutations and protein expression of KIT and PDGFRA genes in ipsilateral testicular seminomas: an immunohistochemical and molecular genetic study.
Terada T
Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):450-3. PubMed ID: 21403518
[TBL] [Abstract][Full Text] [Related]
5. The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated.
Penzel R; Aulmann S; Moock M; Schwarzbach M; Rieker RJ; Mechtersheimer G
J Clin Pathol; 2005 Jun; 58(6):634-9. PubMed ID: 15917417
[TBL] [Abstract][Full Text] [Related]
6. An immunohistochemical and molecular genetic analysis of KIT and PDGFRA in small cell lung carcinoma in Japanese.
Terada T
Int J Clin Exp Pathol; 2012; 5(4):331-8. PubMed ID: 22670177
[TBL] [Abstract][Full Text] [Related]
7. Value of epithelioid morphology and PDGFRA immunostaining pattern for prediction of PDGFRA mutated genotype in gastrointestinal stromal tumors (GISTs).
Agaimy A; Otto C; Braun A; Geddert H; Schaefer IM; Haller F
Int J Clin Exp Pathol; 2013; 6(9):1839-46. PubMed ID: 24040448
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome.
Søreide K; Sandvik OM; Søreide JA; Gudlaugsson E; Mangseth K; Haugland HK
Clin Transl Oncol; 2012 Aug; 14(8):619-29. PubMed ID: 22855146
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours.
Wang C; Jin MS; Zou YB; Gao JN; Li XB; Peng F; Wang HY; Wu ZD; Wang YP; Duan XM
Scand J Gastroenterol; 2013 Sep; 48(9):1055-65. PubMed ID: 23862765
[TBL] [Abstract][Full Text] [Related]
10. Protein expression and gene mutation status of KIT and PDGFRA in renal cell carcinoma.
Terada T
Histol Histopathol; 2012 Mar; 27(3):297-302. PubMed ID: 22237707
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of KIT/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site.
Wasag B; Debiec-Rychter M; Pauwels P; Stul M; Vranckx H; Oosterom AV; Hagemeijer A; Sciot R
Mod Pathol; 2004 Aug; 17(8):889-94. PubMed ID: 15154005
[TBL] [Abstract][Full Text] [Related]
12. Positive immunohistochemical staining of KIT in solid-pseudopapillary neoplasms of the pancreas is not associated with KIT/PDGFRA mutations.
Cao D; Antonescu C; Wong G; Winter J; Maitra A; Adsay NV; Klimstra DS; Hruban RH
Mod Pathol; 2006 Sep; 19(9):1157-63. PubMed ID: 16778826
[TBL] [Abstract][Full Text] [Related]
13. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).
Du CY; Shi YQ; Zhou Y; Fu H; Zhao G
J Surg Oncol; 2008 Sep; 98(3):175-8. PubMed ID: 18618605
[TBL] [Abstract][Full Text] [Related]
14. C-kit and PDGFRA gene mutations in triple negative breast cancer.
Zhu Y; Wang Y; Guan B; Rao Q; Wang J; Ma H; Zhang Z; Zhou X
Int J Clin Exp Pathol; 2014; 7(7):4280-5. PubMed ID: 25120810
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.
Kalfusova A; Linke Z; Kalinova M; Krskova L; Hilska I; Szabova J; Vicha A; Kodet R
Pathol Res Pract; 2019 Dec; 215(12):152708. PubMed ID: 31708372
[TBL] [Abstract][Full Text] [Related]
16. Expression of platelet-derived growth factor-alpha receptor and c-kit in giant cell tumours of bone.
Sulzbacher I; Dominkus M; Pichlhofer B; Mazal PR
Pathology; 2009; 41(7):630-3. PubMed ID: 20001342
[TBL] [Abstract][Full Text] [Related]
17. KIT exon 11 codon 557/558 deletion/insertion mutations define a subset of gastrointestinal stromal tumors with malignant potential.
Kontogianni-Katsarou K; Dimitriadis E; Lariou C; Kairi-Vassilatou E; Pandis N; Kondi-Paphiti A
World J Gastroenterol; 2008 Mar; 14(12):1891-7. PubMed ID: 18350628
[TBL] [Abstract][Full Text] [Related]
18. Expression of c-kit in fibroepithelial lesions of the breast is a mast cell phenomenon.
Djordjevic B; Hanna WM
Mod Pathol; 2008 Oct; 21(10):1238-45. PubMed ID: 18500266
[TBL] [Abstract][Full Text] [Related]
19. Primary small cell carcinoma of the maxillary sinus: a case report with immunohistochemical and molecular genetic study involving KIT and PDGFRA.
Terada T
Int J Clin Exp Pathol; 2012; 5(3):264-9. PubMed ID: 22558483
[TBL] [Abstract][Full Text] [Related]
20. [Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST)].
He HY; Fang WG; Zhong HH; Li Y; Zheng J; Du J; Heng WJ; Wu BQ
Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):262-6. PubMed ID: 16776995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]